Sign inJoin waitlistJoin the waitlist

Ayed Ayed

Physician · Cancer Specialists LLC

Credentials: · · · · · ·

History

Cancer Specialists LLC
Present

Mayo Clinic
2014–2017
Internal Medicine
Shands Hospital at the University of Florida - Gainesville
2011–2014
University of Jordan
2007–2011

Research

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy
Blood · 2024 · 124 citations
Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia
The Journal of Experimental Medicine · 2018 · 87 citations
Relationship of serum imatinib trough level and response in CML patients: long term follow-up
Leukemia Research · 2010 · 34 citations

GN
Grzegorz Nowakowski
2 papers
IF
Ian Flinn
2 papers
JS
Jeff Sharman
2 papers
Tara Graff
2 papers
AM
Abdul Hai Mansoor
1 paper
AP
Adam Petrich
1 paper
AW
Adrian Wiestner
1 paper
AC
Agnes Cha
1 paper
AA
Ahmad Alkhasawneh
1 paper
Alessandra Ferrajoli
1 paper
AH
Alex Herrera
1 paper
AZ
Andrew Zelenetz
1 paper

Clinical trials

A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Site PI · Recruiting · Phase 4
Eli Lilly and Company
2026–2032
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Site PI · Recruiting · Phase 4
Eli Lilly and Company
2025–2032
A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Site PI · Recruiting · Phase 3
Loxo Oncology, Inc.
2022–2028